×

Halozyme to license drug delivery tech to Bristol-Myers and Roche

3:43 PM ET Thu, 14 Sept 2017

Halozyme CEO Dr. Helen Torley speaks with CNBC's Meg Tirrell about the company using technology that makes it easier for patients to take medicine.